• 9717238330
  • info@rahepharmacy.com
/storage/photos/46/Vaccine.jpg

Zydus’ vaccine for kids above 12 to come up for approval this week


The official said that once approval is given, supply of the vaccine is expected to start by August-September. If it gets the nod, ZyCov-D, a locally developed DNA vaccine candidate would be the fifth vaccine against coronavirus to get EUA in India. Currently, Covishield, Covaxin and Sputnik V are being administered under the national Covid-19 immunisation programme. Cipla has also got an EUA to import Moderna’s anti-Covid jab but it is yet to be available in the country.


ZyCoV-D is a three-dose, intradermal vaccine which is applied using the PharmaJet needle-free system. It can be stored at 2-8 degree Celsius and has shown good stability at temperatures of 25 degree Celsius for at least 3 months. While Zydus Cadila has indicated it will initially manufacture one crore doses per month and later increase production, the vaccine’s availability will be a boost to supplies as well as offer cover to children of 12-18 years, particularly in the wake of concerns about a potential third wave as children are seen to be vulnerable to the virus.

You need to Login OR Register for comment.

Comments (0)